New York Oncology Hematology, Pc

Troy, New York 12180

0 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Kidney Neoplasms, Metastatic Breast Cancer

Studies at this site

• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed
• Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic — Completed
• Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor — Completed